+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions



Treatment of hydatid disease with high oral doses of mebendazole. Long-term follow-up of plasma mebendazole levels and drug interactions



European Journal of Clinical Pharmacology 31(4): 443-448



Plasma mebendazole levels were analysed retrospectively in patients treated for inoperable infections with Echinococcus multilocularis or granulosus. In 10 patients receiving mebendazole at 4 dose levels there was no relation between dose and plasma concentration. In 17 patients followed on the same dose for more than 18 months, the plasma levels varied with individual coefficients of variation ranging from 27 to 72%. The data reveal the limitations of single measurements of plasma mebendazole and emphasize the need for repeated monitoring. Coadministration of phenytoin and carbamazepine seemed to lower plasma levels, presumably as a result of enzyme induction. It was not possible appreciably to raise the mebendazole concentrations by inhibition of drug metabolizing enzymes with cimetidine.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 041854870

Download citation: RISBibTeXText

PMID: 3816925


Related references

Long term follow-up of human hydatid disease (Echinococcus granulosus) treated with a high-dose mebendazole regimen. American Journal of Tropical Medicine and Hygiene 33(1): 132-137, 1984

Experimental treatment of alveolar hydatid disease x. the effect of mebendazole bcg or mebendazole levamisole combinations on the course of hydatid disease simulated in mice. Meditsinskaya Parazitologiya i Parazitarnye Bolezni (6): 27-31, 1986

Mebendazole in the treatment of the acute and chronic stages of helminthiases. II. Mebendazole (Vermox) in the treatment of alveolar hydatid disease and echinococcosis. Meditsinskaia Parazitologiia i Parazitarnye Bolezni 48(5): 17-24, 1979

Long term high dose mebendazole for cystic hydatid disease of liver failure in 2 cases. Australian & New Zealand Journal of Surgery 51(1): 23-27, 1981

Long-term high-dose mebendazole for cystic hydatid disease of liver: failure in two cases. Australian and New Zealand Journal of Surgery 51(1): 23-27, 1981

High mebendazole doses in pulmonary and hepatic hydatid disease. Archives of Disease in Childhood 66(4): 532-533, 1991

Plasma levels of mebendazole in children with hydatid disease. Annals of Tropical Paediatrics 12(4): 441-443, 1992

Therapy of human hydatid disease with mebendazole: first attempts of correlating plasma and cyst levels with therapeutic results. Giornale di Malattie Infettive e Parassitarie 37(1/3): 88-90, 1985

Treatment of experimental peritoneal hydatid disease in BALB/C mice with oral mebendazole and flubendazole. Annali Sclavo 22(5): 831-836, 1980

Experimental chemotherapy of alveolar hydatid disease. 12. The efficacy of drug forms of mebendazole and nocodazole with high bioavailability. Meditsinskaia Parazitologiia i Parazitarnye Bolezni .(5): 43-46, 1989

Abdominal hydatid disease: follow-up of mebendazole therapy by CT and ultrasonography. International Surgery 71(1): 22-26, 1986

Chemotherapy of human hydatid disease with mebendazole. Follow-up of 16 cases. Acta Gastro-Enterologica Belgica 43(1-3): 48-65, 1980

Medical therapy with mebendazole in hydatid cyst disease. A follow-up of 40 cases. Minerva Medica 80(3): 205-214, 1989

Residue study of mebendazole and its metabolites hydroxy-mebendazole and amino-mebendazole in eel (Anguilla anguilla) after bath treatment. Drug Metabolism and Disposition: the Biological Fate of Chemicals 25(3): 317-320, 1997

Treatment of hydatid disease with mebendazole. Turkiye Parazitoloji Dergisi 5(2): 17-24, 1982